pharmaphorum| News & views on pharma and biotech’s evolving future

Patients

Man lies on floor next to spilled pill bottle, reference to overdose

Decline in overdose deaths ≠ The end of the opioid crisis

Since 2001, International Overdose Day has been observed as a moment to remember those lost to overdose and renew society’s commitment to

News

ESC26: Can Arrowhead pierce Ionis' triglyceride armour?

Arrowhead Pharma is squaring up to rival Ionis in the severe hypertriglyceridaemia (sHTG) market, drawing on phase 3 data at ESC 2026.

Oncology

How IRA, MFN, and HTA are rewriting oncology launch strategy...

News

ESC26: AZ's relaxin agonist shows promise in heart failure

An oral relaxin agonist developed by AstraZeneca, codenamed AZD5462, has been shown to improve cardiac function in patients with heart failure.

News

FDA clears Takeda, Protagonist's first-in-class PV drug

Takeda and Protagonist's hepcidin mimetic rusfertide is the first hepcidin mimetic to be approved by the FDA for blood cancer polycythaemia vera.

Featured Content

Patients

Decline in overdose deaths ≠ The end of the opioid crisis

Since 2001, International Overdose Day has been observed as a moment to remember those lost to overdose and renew society’s commitment to

Oncology

How IRA, MFN, and HTA are rewriting oncology launch strategy...

/themes/custom/pharmaphorum_theme/library/img/article-label-image/ondemand.png

Digital

Sponsored

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

Patients

pharmaphorum podcast Episode 273, James Davis, PA Consulting

Deliver prevention at scale, PA Consulting’s James Davis

James Davis, a healthcare expert at PA Consulting, discusses the digital foundations needed to unlock a prevention first NHS.

R&D

two healthcare professionals looking at chart

Sponsored

Decentralisation by design: Bringing the trial closer withou...

In the third episode of the IQVIA-sponsored PSCS leadership video series, Sinead Callinan, Head of Patient Centred Delivery, discusses DCTs.

R&D

Sponsored

From Alzheimer’s disease research to the real-world setting:...

In a new white paper, Lucid Strategy Consulting suggests three key themes for pharma strategists seeking market leadership in the Alzheimer's space.

Newsletters and Deep Dive
digital magazine

Latest News

News

ESC26: Can Arrowhead pierce Ionis' triglyceride armour?

Arrowhead Pharma is squaring up to rival Ionis in the severe hypertriglyceridaemia (sHTG) market, drawing on phase 3 data at ESC 2026.

News

ESC26: AZ's relaxin agonist shows promise in heart failure

An oral relaxin agonist developed by AstraZeneca, codenamed AZD5462, has been shown to improve cardiac function in patients with heart failure.

News

FDA clears Takeda, Protagonist's first-in-class PV drug

Takeda and Protagonist's hepcidin mimetic rusfertide is the first hepcidin mimetic to be approved by the FDA for blood cancer polycythaemia vera.

News

ESC26: Cytokinetics' big data reveal for Myqorzo impresses

Cytokinetics has revealed highly anticipated data from the ACACIA-HCM study of Myqorzo in non-obstructive hypertrophic cardiomyopathy at ESC 2026.

Views & Analysis

Patients

Decline in overdose deaths ≠ The end of the opioid crisis

Since 2001, International Overdose Day has been observed as a moment to remember those lost to overdose and renew society’s commitment to

Market Access

Navigating Europe's AI regulatory labyrinth: A strategic gui...

For US drug developers, bringing AI tools across the Atlantic introduces steep regulatory hurdles.

R&D

Why the future of eSource starts with the research site

Capturing data digitally at source can significantly reduce the workflow for sites, yet, implementing it across studies has been rather unattainable.

Market Access

Biotech funding has returned. The bar has moved with it.

For biotech sponsors, the question worth asking is not whether the rebound is real, but what it is actually rewarding.

Deep Dive

Oncology

How IRA, MFN, and HTA are rewriting oncology launch strategy...

R&D

Cancer misinformation is a trust problem, not just an inform...

Oncology

Solving the ovarian cancer diagnostic and treatment pathway ...

Oncology

Early onset cancer new approach treatment

White Papers & Webinar

R&D

Sponsored

From Alzheimer’s disease research to the real-world setting:...

In a new white paper, Lucid Strategy Consulting suggests three key themes for pharma strategists seeking market leadership in the Alzheimer's space.

Digital

Sponsored

Discover a new era of healthcare panel engagement: Grounded ...

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.

R&D

From obesity to outcomes abstract visual

Sponsored

The future of cardiometabolic trials: From obesity to outcom...

Gain practical insight into how leading experts are designing the next generation of cardiometabolic trials in an upcoming webinar from hVIVO

R&D

Sponsored

A data-driven guide to small molecule drug discovery and dev...

A new white paper from Excelra takes a closer look at how discovery teams actually experience the small molecule development journey.

Podcasts & Video

Patients

Deliver prevention at scale, PA Consulting’s James Davis

James Davis, a healthcare expert at PA Consulting, discusses the digital foundations needed to unlock a prevention first NHS.

R&D

Sponsored

Decentralisation by design: Bringing the trial closer withou...

In the third episode of the IQVIA-sponsored PSCS leadership video series, Sinead Callinan, Head of Patient Centred Delivery, discusses DCTs.

R&D

pharmaphorum podcast Episode 272, Dr Harpreet Singh, Precision for Medicine

Understanding Operation Trialblazer, with Dr Harpreet Singh

Dr Harpreet Singh, CMO at Precision for Medicine, brings both an insider and outsider perspective to discussing Operation TRIALBLAZER.

R&D

Prevent-Stop-Cure: Diagnostics & chronic liver disease, with...

Partner Content

Event

Partner Content

World Novel Drug Discovery Summit South Korea

Korea’s First Industry Forum Driving Best-in-Class Discovery for Next-Generation Modalities

Event

Partner Content

2nd World-RNA Based Therapeutics & Vaccines Summit South Kor...

Korea’s Forum to Advance mRNA, CircRNA & saRNA Medicines for Clinical & Commercial Readiness

Event

Media Partner

AI, Forecasting, Insights and Analytics for Smarter Decision...

Learn from case studies, expert-led panels, roundtable discussions, and interactive workshops on Gen AI-powered forecasting

Event

Media Partner

30th Portfolio Decision-Making & Prioritisation for Pharma

Pharmaceutical portfolio decision-making is facing structural pressure.

Event

Media Partner

R&D Governance, Controlling and Innovation for Pharma

The Marcus Evans R&D Governance, Controlling, and Innovation for Pharma conference will take place at the Crowne Plaza - Frankfurt Congress Hotel

Featured Content

Editor's Picks

Latest News

Views & Analysis

Deep Dive

White Papers & Webinar

Podcasts & Video

Partner Content